• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383647
Device Problems Leak/Splash (1354); Device Contamination with Chemical or Other Material (2944)
Patient Problem Venipuncture (2129)
Event Date 06/19/2020
Event Type  Injury  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that redness occurred at the puncture site through the entire length of the bd nexiva¿ closed iv catheter system, causing extravasations that were mainly noticed on the third day of placement.An "x-ray, ct scan, magnet, gastroscopy, and ercp" were performed, antibiotics given, and the catheter was replaced.This complaint was created to capture the 2nd of 2 related incidents.The following information was provided by the initial reporter: "redness occurs at the puncture site through the entire length of the catheter.Moreover, area outside of the fixative is also red what is supported by the image.Furthermore, they also noticed and monitored extravasations due to the insertion of catheter.These situations mostly arises on third day of the catheter insertion which force nurses to replace the catheter." "x-ray, ct scan, magnet, gastroscopy, ercp, administration of antibiotics.".
 
Event Description
It was reported that redness occurred at the puncture site through the entire length of the bd nexiva¿ closed iv catheter system, causing extravasations that were mainly noticed on the third day of placement.An "x-ray, ct scan, magnet, gastroscopy, and ercp" were performed, antibiotics given, and the catheter was replaced.This complaint was created to capture the 2nd of 2 related incidents.The following information was provided by the initial reporter: "redness occurs at the puncture site through the entire length of the catheter.Moreover, area outside of the fixative is also red what is supported by the image from the attachment.Furthermore, they also noticed and monitored extravasations due to the insertion of catheter.These situations mostly arises on third day of the catheter insertion which force nurses to replace the catheter." "x-ray, ct scan, magnet, gastroscopy, ercp, administration of antibiotics.".
 
Manufacturer Narrative
H.6.Investigation summary a physical sample was not available for investigation but bd was provided with three photos of the issue for evaluation.A review of the device history record was performed for the reported lot, 9221847, and no quality issues were found during production.The lot was documented as being properly sterilized with no issues observed.Our quality engineer reviewed the provided photos and observed a 20 gauge nexiva unit in use with a transparent dressing placed over the insertion site.There are traces of media present at the insertion site and down a portion of the extension line indicating a successful activation.However, there is also visible redness at the insertion site that runs partially up the arm.Based off the provided photos the engineer was able to verify the reported defect.Unfortunately, a definitive root cause could not be determined without a physical sample available for testing.It was also reported that extravasations were observed and monitored due to the insertion.This could be a contributing factor as well.The manufacturing facility has been notified of this incident and the findings.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA CLOSED IV CATHETER SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key10258917
MDR Text Key198786160
Report Number1710034-2020-00439
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
K183399
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Type of Report Initial,Followup
Report Date 08/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/30/2022
Device Catalogue Number383647
Device Lot Number9284508
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/20/2020
Initial Date FDA Received07/10/2020
Supplement Dates Manufacturer Received06/20/2020
Supplement Dates FDA Received08/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-